INDUCE: A Prospective 2-Year Spine Registry

Not yet recruitingOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

October 31, 2025

Primary Completion Date

December 31, 2028

Study Completion Date

January 31, 2029

Conditions
Subjects Treated With NMP as Part of Their Spine SurgeryDegenerative Disc Disease (DDD)
Interventions
DEVICE

NMP

"The study product is Induce Biologics NMP Fibers and NMP Micro Particulates however, this is observational research that involves standard of care.~NMP is regulated as a human cellular or tissue-based product (HCT/P) under section 361 of the Public Health Service (PHS) Act and in 21 CFR Part 1271. Under this regulation it did not require clinical evaluation before it could be used commercially. It is indicated for use as a bone void filler for filling voids and gaps in the skeletal system that are not intrinsic to the stability of the boney structure."

All Listed Sponsors
lead

Red Rock Regeneration Inc.

INDUSTRY

NCT06971835 - INDUCE: A Prospective 2-Year Spine Registry | Biotech Hunter | Biotech Hunter